| Ytd | 7.20% | |
| 1y | 5.51% |
| Open | 1.31 | Prev Close | 1.31 | Low | 1.29 | High | 1.36 | Mkt Cap | 69.86M |
| Vol | 67.45K | Avg Vol | 338.42K | EPS | -1.49 | P/E | -0.88 | Forward P/E | -0.96 |
| Beta | 1.33 | Short Ratio | 5.17 | Inst. Own | 83.89% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 1.23 | 200-d Avg | 1.30 | 1yr Est | 5.80 |
PMVP News
PMV Pharmaceuticals (PMVP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism a
PMV Pharmaceuticals (PMVP) is technically in oversold territory now, so the heavy selling pressure m
Rich Heyman to retire from PMV Pharma Board of Directors; Laurie Stelzer, Director since 2020, appoi
PRINCETON, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “
Aurinia Pharmaceuticals (NASDAQ: AUPH - Get Free Report) and PMV Pharmaceuticals (NASDAQ: PMVP - Get
PRINCETON, N.J., Oct. 24, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “C
PMV Pharmaceuticals, Inc. PMVP on Wednesday released interim data from the Phase 2 pivotal portion o
PRINCETON, N.J., Sept. 10, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “
PMV Pharmaceuticals (PMVP) Q2 Loss Jumps
PRINCETON, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “C
PRINCETON, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma”; Nasdaq: P
PMV Pharmaceuticals (PMVP) witnesses a hammer chart pattern, indicating support found by the stock a
Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as m
PRINCETON, N.J., Feb. 11, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a preci
PMV Pharmaceuticals (PMVP) appears to have found support after losing some value lately, as indicate
BOSTON & PRINCETON, N.J.--(BUSINESS WIRE)--Foundation Medicine and PMV Pharma partner to develop Fou
BOSTON and PRINCETON, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Foundation Medicine, Inc. and PMV Pharm
PRINCETON, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precis
PRINCETON, N.J., March 27, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a prec
PRINCETON, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a prec
On Friday, 497 companies set new 52-week lows.
Monday saw 196 companies set new 52-week lows.
On Tuesday, 951 companies hit new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
On Friday, 209 companies set new 52-week lows.
Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the comp